359 related articles for article (PubMed ID: 23964873)
1. [Vogt-Koyanagi-Harada syndrome in children - a case report].
Bušányová B; Tomčíková D; Gerinec A
Cesk Slov Oftalmol; 2013 Jun; 69(2):81-6. PubMed ID: 23964873
[TBL] [Abstract][Full Text] [Related]
2. Treatment of persistent serous retinal detachment in Vogt-Koyanagi-Harada syndrome with intravitreal bevacizumab during the systemic steroid treatment.
Reibaldi M; Russo A; Avitabile T; Uva MG; Franco L; Longo A; Toro MD; Cennamo G; Mariotti C; Neri P; Noci ND; Russo V
Retina; 2014 Mar; 34(3):490-6. PubMed ID: 23903795
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal bevacizumab injection for persistent serous retinal detachment associated with Vogt-Koyanagi-Harada disease.
Park HS; Nam KY; Kim JY
Graefes Arch Clin Exp Ophthalmol; 2011 Jan; 249(1):133-6. PubMed ID: 20689964
[TBL] [Abstract][Full Text] [Related]
4. Rebound inflammation after an intravitreal injection in Vogt-Koyanagi-Harada syndrome.
Ranjan R; Agarwal M
Indian J Ophthalmol; 2018 Jun; 66(6):863-865. PubMed ID: 29786006
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal bevacizumab injection in a 14-year-old Vogt-Koyanagi-Harada patient with choroidal neovascular membrane.
Raffa L; Bawazeer A
Can J Ophthalmol; 2009 Oct; 44(5):615-6. PubMed ID: 19789612
[No Abstract] [Full Text] [Related]
6. Choroidal Detachment following an Intravitreal Injection in a Patient with Vogt-Koyanagi- Harada Disease.
Kumar N; Rana N; Bansal R
Ocul Immunol Inflamm; 2021 Feb; 29(2):396-398. PubMed ID: 31664881
[No Abstract] [Full Text] [Related]
7. Intravitreal bevacizumab for choroidal neovascularization secondary to Vogt-Koyanagi-Harada syndrome.
Wu L; Evans T; Saravia M; Schlaen A; Couto C
Jpn J Ophthalmol; 2009 Jan; 53(1):57-60. PubMed ID: 19184312
[TBL] [Abstract][Full Text] [Related]
8. Topical difluprednate for treatment of serous retinal detachment and panuveitis associated with Vogt-Koyanagi-Harada disease.
Lu S; Taban M
Digit J Ophthalmol; 2016; 22(2):54-7. PubMed ID: 27582676
[TBL] [Abstract][Full Text] [Related]
9. Management of recurrent inflammatory choroidal neovascular membrane secondary to Vogt-Koyanagi-Harada syndrome, using combined intravitreal injection of bevacizumab and triamcinolone acetate.
Pai SA; Hebri SP; Lootah AM
Indian J Ophthalmol; 2012; 60(6):551-2. PubMed ID: 23202396
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal triamcinolone in the treatment of serous retinal detachment in Vogt-Koyanagi-Harada syndrome.
Andrade RE; Muccioli C; Farah ME; Nussenblatt RB; Belfort R
Am J Ophthalmol; 2004 Mar; 137(3):572-4. PubMed ID: 15013890
[TBL] [Abstract][Full Text] [Related]
11. Vogt-Koyanagi-Harada disease in 3-year-old boy.
Takada S; Tanaka R; Kurita N; Ishii K; Kaburaki T
Clin Exp Ophthalmol; 2015 Aug; 43(6):593-4. PubMed ID: 25711345
[No Abstract] [Full Text] [Related]
12. Vogt-Koyanagi-Harada syndrome in an 11-year-old Boy.
Ikeda N; Hayasaka S; Kadoi C; Nagaki Y
Ophthalmologica; 1999; 213(3):197-9. PubMed ID: 10202295
[TBL] [Abstract][Full Text] [Related]
13. Bilateral disc edema in a patient with Vogt-Koyanagi-Harada disease.
Yang HK; Park KH; Kim JS; Hwang JM
Can J Ophthalmol; 2014 Apr; 49(2):e54-6. PubMed ID: 24767242
[No Abstract] [Full Text] [Related]
14. Bilateral retinal detachment in a patient with Vogt-Koyanagi-Harada syndrome.
McGehee BE; Chaljub G; Shah RK; Oto A; Camacho AC; Tang RA
Emerg Radiol; 2005 Nov; 11(6):366-71. PubMed ID: 16237574
[TBL] [Abstract][Full Text] [Related]
15. Case Report of a 4-Year-Old Child with Complicated Vogt-Koyanagi-Harada at a Tertiary Eye Hospital.
AlQahtani DS; Al Shamrani M
Middle East Afr J Ophthalmol; 2019; 26(2):117-119. PubMed ID: 31543672
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of pulse corticosteroid therapy for vogt-koyanagi-harada disease assessed by optical coherence tomography.
Yamanaka E; Ohguro N; Yamamoto S; Nakagawa Y; Imoto Y; Tano Y
Am J Ophthalmol; 2002 Sep; 134(3):454-6. PubMed ID: 12208266
[TBL] [Abstract][Full Text] [Related]
17. Mutton fat-like subretinal precipitates associated with Vogt-Koyanagi-Harada disease.
Hamabata K; Hashizume K; Ishikawa Y; Fujiwara T; Machida S; Kurosaka D
Ocul Immunol Inflamm; 2010 Jan; 18(1):44-5. PubMed ID: 20128649
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of Intravitreal Bevacizumab in Choroidal Neovascularization in Vogt-Koyanagi-Harada Disease- A Prospective Study.
Sakata VM; Morita C; Lavezzo MM; Rodriguez EEC; Abdallah SF; Pimentel SLG; Hirata CE; Yamamoto JH
Ocul Immunol Inflamm; 2021 Apr; 29(3):572-578. PubMed ID: 31746659
[No Abstract] [Full Text] [Related]
19. Optical Coherence Tomography-Based Quantification of Photoreceptor Injury and Recovery in Vogt-Koyanagi-Harada Uveitis.
Bae SS; Forooghian F
Ocul Immunol Inflamm; 2017 Jun; 25(3):338-343. PubMed ID: 26903383
[TBL] [Abstract][Full Text] [Related]
20. [Vogt-Koyanagi-Harada disease complicated by subretinal neovessels].
Lepvrier-Guibal N; Korobelnik JF; Xuan TH
J Fr Ophtalmol; 1995; 18(4):305-11. PubMed ID: 7769166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
